about
Yhh1p/Cft1p directly links poly(A) site recognition and RNA polymerase II transcription terminationProtein monoubiquitination and polyubiquitination generate structural diversity to control distinct biological processesDifferential effects of tissue culture coating substrates on prostate cancer cell adherence, morphology and behaviorPhenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironmentIndependent functions of yeast Pcf11p in pre-mRNA 3' end processing and in transcription termination.Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapyTargeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour developmentIdentification of eusynstyelamide B as a potent cell cycle inhibitor following the generation and screening of an ascidian-derived extract library using a real time cell analyzer.Cyclin-dependent kinase-mediated phosphorylation of RBP1 and pRb promotes their dissociation to mediate release of the SAP30·mSin3·HDAC transcriptional repressor complex.The role of the yeast cleavage and polyadenylation factor subunit Ydh1p/Cft2p in pre-mRNA 3'-end formationIsolation, structure determination and cytotoxicity studies of tryptophan alkaloids from an Australian marine sponge Hyrtios sp.Design and Synthesis of a Screening Library Using the Natural Product Scaffold 3-Chloro-4-hydroxyphenylacetic Acid.Cytotoxic C20 Diterpenoid Alkaloids from the Australian Endemic Rainforest Plant Anopterus macleayanus.The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cellsControl of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates.Discovery of Thalicthuberine as a Novel Antimitotic Agent from Nature that Disrupts Microtubule Dynamics and Induces Apoptosis in Prostate Cancer Cells.6α-Acetoxyanopterine: A Novel Structure Class of Mitotic Inhibitor Disrupting Microtubule Dynamics in Prostate Cancer Cells.Bioactive Dihydro-β-agarofuran Sesquiterpenoids from the Australian Rainforest Plant Maytenus bilocularis.Denhaminols A-H, dihydro-β-agarofurans from the endemic Australian rainforest plant Denhamia celastroides.The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancerCdc34 C-terminal tail phosphorylation regulates Skp1/cullin/F-box (SCF)-mediated ubiquitination and cell cycle progression.Molecular basis for lysine specificity in the yeast ubiquitin-conjugating enzyme Cdc34.Mechanisms of mono- and poly-ubiquitination: Ubiquitination specificity depends on compatibility between the E2 catalytic core and amino acid residues proximal to the lysine.Geminin and Brahma act antagonistically to regulate EGFR-Ras-MAPK signaling in Drosophila.Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion.Identification of Gibberellic Acid Derivatives That Deregulate Cholesterol Metabolism in Prostate Cancer Cells.A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome
P50
Q24534246-EE228F28-924A-4C7D-BC07-1E683202DB36Q26865081-78DE96A8-FA32-4AD9-AE62-C46180E3A793Q27331332-4D69D08E-791F-46DC-B568-62FB77BADCA0Q27335274-7CF7BCD0-4888-448F-BDE1-585E79FDB65DQ27933119-A3318E71-DB77-46F8-B206-AD1B09DD81A5Q28829239-F51E3BA7-E611-439A-BEAA-884607224B02Q28831339-D8C4A609-ABEF-409B-A540-772D5444F914Q34411545-21D83744-DF42-4BC0-8FBC-B3E7D2B82B5BQ34568327-0DB281F3-CBB9-4291-8979-90B34741B649Q35186139-283081ED-C22F-4FAE-B97A-BCCBBC1A3EFDQ35196722-CD9FA2C4-288B-4457-A728-21FBA6FB0F8EQ35585285-2342E8F0-3F80-4E45-9776-ACB50EBBFA7DQ35850541-570A375F-DE74-41F2-B96A-14F8E1CF7E7BQ36685541-B3FF9934-F8A5-4C35-A462-C7D014927D8AQ37718853-DD173232-8DE1-4576-8296-EAE30D0BB11FQ38651098-FB31BECD-423B-43BE-9A86-B8ACFCD7CC69Q38739637-A07E4171-1170-4A32-9211-05105D861111Q38775032-58C4875A-C902-4B3B-B3A3-E0F166ACB611Q38920944-149F2D35-FDBA-4683-9052-DB6E53B2BECBQ38948059-F8CCEF6E-BAB4-4168-AB16-E9853D31B5C3Q40140650-2B275069-78DC-434C-BF44-C5458ACFBFB2Q40337840-9FCD7C92-C10F-422D-8F55-27C50AE5A201Q42493490-7B5F8682-74E2-4A52-9B4B-43888D908995Q47071867-6F9495DC-380E-4B5D-A5FC-FB3E43C5D6A7Q48121004-FADBC530-6471-428B-8FB0-3AF5117B4D2DQ52688500-A2D894F1-CF33-4BC8-BB7B-7931352D9469Q91336482-C7E16B22-BC13-4FE8-84BF-3C565FF3F29C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Martin Sadowski
@ast
Martin Sadowski
@en
Martin Sadowski
@es
Martin Sadowski
@nl
Martin Sadowski
@sl
type
label
Martin Sadowski
@ast
Martin Sadowski
@en
Martin Sadowski
@es
Martin Sadowski
@nl
Martin Sadowski
@sl
prefLabel
Martin Sadowski
@ast
Martin Sadowski
@en
Martin Sadowski
@es
Martin Sadowski
@nl
Martin Sadowski
@sl
P106
P31
P496
0000-0002-5267-1442